about
Inhibition of microRNA function by antimiR oligonucleotidesMicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signalingEpigenetic associations in relation to cardiovascular prevention and therapeuticsOncogenic MicroRNAs: Key Players in Malignant TransformationMicroRNAS in endometrial cancer: recent advances and potential clinical applicationsBiomarker-based MicroRNA Therapeutic Strategies for Hepatocellular CarcinomaMicroRNAs and Potential Targets in Osteosarcoma: ReviewsiRNA Versus miRNA as Therapeutics for Gene SilencingMicroRNAs as pharmacological targets in diabetesEmerging therapeutic biomarkers in endometrial cancermiR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimirAntiviral activity of salivary microRNAs for ophthalmic herpes zostermicroRNAs in spinal cord injury: potential roles and therapeutic implicationsTargeting microRNAs for immunomodulationMicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancerUsing microRNA as an alternative treatment for hyperlipidemia and cardiovascular disease: cardio-miRs in the pipelineMicroRNA-Based Therapy in Animal Models of Selected Gastrointestinal CancersTherapeutic use of microRNAs in lung cancerAptamer-Dendrimer Bioconjugates for Targeted Delivery of miR-34a Expressing Plasmid and Antitumor Effects in Non-Small Cell Lung Cancer CellsPigmy MicroRNA: surveillance cops in Therapies kingdomMicroRNAs Used in Combination with Anti-Cancer Treatments Can Enhance Therapy EfficacyRegulation of Collagen V Expression and Epithelial-Mesenchymal Transition by miR-185 and miR-186 during Idiopathic Pulmonary Fibrosis.microRNA in the development of diabetic complications.A novel vector-based method for exclusive overexpression of star-form microRNAsMicroRNA-320a is downregulated in non-small cell lung cancer and suppresses tumor cell growth and invasion by directly targeting insulin-like growth factor 1 receptor.RNA metabolism in neurodegenerative disease.In silico identification of plant miRNAs in mammalian breast milk exosomes--a small step forward?The roles of individual mammalian argonautes in RNA interference in vivo.The potential of microRNAs in personalized medicine against cancers.Non-coding RNAs in cerebral endothelial pathophysiology: emerging roles in stroke.Exploiting microRNA regulation for genetic engineering.Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology.Contribution of bioinformatics prediction in microRNA-based cancer therapeutics.Transforming growth factor-β induces microRNA-29b to promote murine alveolar macrophage dysfunction after bone marrow transplantationAberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets?Gene Therapies for Cancer: Strategies, Challenges and Successes.Cardiac insulin resistance and microRNA modulators.The CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiationMicroRNAs: short non-coding players in cancer chemoresistance.miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy.
P2860
Q21198757-FD0DD032-97F7-4DFB-A168-5CDA38E2FC70Q26740198-8D13D92A-9974-4621-A86D-5F7554165A6EQ26771428-44414B39-DEBA-4846-A08F-F36BB4D5DB32Q26773316-9F68352A-75D6-4A80-B5A5-8EF549429469Q26780358-29CFB6DE-5589-400B-A1A7-5CB1AFE12F20Q26782003-6A8745C2-5900-452F-9B47-86457488C1F1Q26784033-1832E092-C7EF-4E56-8947-96106BA63E4AQ26786876-C5885646-2741-4F4E-AB34-190EF8E22F97Q26824024-D2E20478-71CC-4277-8BA9-54AA7CF9D420Q26865904-DBA457B0-BDCD-488C-B658-4AE3C4806D5FQ26991956-D387AD32-1E09-4517-9B64-D05759A01874Q26999070-DE4793E6-A9ED-4BD2-AB65-F8F6773BCD6EQ27009439-FAB1EE51-5686-4391-9F07-FEAE422C9556Q27014065-103B51DE-3E0A-43BE-B813-A0179A8E9497Q27022048-0CE16036-6316-43B2-A2B0-5969F53AEEA0Q27694686-AF4144CD-4C3E-446A-8D15-BE71C2F1FF36Q28076754-2600EC0F-3E24-4F19-BA8B-7EE097007A4CQ28395179-A6DF2076-1B29-4C01-87D1-D5FA3E655FFCQ28548503-DDA1D923-A6A3-4D32-AB20-13083ADD1ADFQ28818470-EC4DFD6D-8830-4B71-BE0E-838A02EB2629Q28829013-26902D4C-55B7-4141-AFB7-136E429109CDQ30276395-8FF2300F-4268-4D86-A18D-5962DFAEC5C6Q30353835-8B622A98-9CBF-4222-8DB3-1D8896456F23Q31077032-F6A47A28-E235-492F-ACBB-55F7FCB56B54Q33684987-EA24F5D2-B4D6-4A95-8326-43124661D2ABQ33746283-E7D9EDC4-7319-4EDE-8033-7D3B2A1E98AFQ33763532-87D10EA9-A05C-49E5-A906-67B12ACF16B7Q33846059-D3109E31-6528-49FE-9304-DF5FCEEF4995Q34177547-F19D0AC5-FB6A-4102-B3A3-0B95DADE3B42Q34254370-3A550D1F-B00D-4F52-B914-65F1C666B39DQ34302499-993A3234-6B3B-42D4-88ED-8FE49E4616A2Q34485522-F151643A-4B3A-4753-B08D-1BD0F4473DF3Q34775580-9D046045-8EBA-4BB4-A490-25CB118AA0BEQ34801214-187880B0-0B4C-4362-A303-0770F62318B8Q35019375-D5ECE94A-82DD-4FE6-A045-459BE01384FDQ35186312-F48A05DD-5566-4E23-B938-E977E9C908CFQ35251097-ED781C9B-0A28-4244-972E-052F0B7DBA1FQ35280248-762AE9C2-48EC-4D0F-B6B7-F9E34A995999Q35673637-19084847-FE00-4E3E-A278-7DDDB9D00EB7Q35681504-4CEE6429-EF54-46C3-89B2-34DD070F2BFE
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA therapeutics.
@en
MicroRNA therapeutics.
@nl
type
label
MicroRNA therapeutics.
@en
MicroRNA therapeutics.
@nl
prefLabel
MicroRNA therapeutics.
@en
MicroRNA therapeutics.
@nl
P2860
P356
P1433
P1476
MicroRNA therapeutics
@en
P2093
J A Broderick
P2860
P2888
P304
P356
10.1038/GT.2011.50
P577
2011-04-28T00:00:00Z